Co-Diagnostics Balance Sheet Health
Financial Health criteria checks 6/6
Co-Diagnostics has a total shareholder equity of $144.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $160.8M and $16.4M respectively. Co-Diagnostics's EBIT is $29.6M making its interest coverage ratio -316.7. It has cash and short-term investments of $96.0M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -316.7x |
| Cash | US$96.00m |
| Equity | US$144.47m |
| Total liabilities | US$16.37m |
| Total assets | US$160.84m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: C97's short term assets ($114.6M) exceed its short term liabilities ($6.7M).
Long Term Liabilities: C97's short term assets ($114.6M) exceed its long term liabilities ($9.7M).
Debt to Equity History and Analysis
Debt Level: C97 is debt free.
Reducing Debt: C97 currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Debt Coverage: C97 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: C97 has no debt, therefore coverage of interest payments is not a concern.